Wednesday 14 October 2026
Export OSCR’s income statement to Excel — free account
Oscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
33.79
0.22
−0.65%
Follow OSCR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 4 | 3 | 4 |
+8 more TTM periods Free account |
| 34.24% | (2.63%) | (44.38%) | (22.27%) | ||
| 6.25% | (0.52%) | (7.94%) | (4.77%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(15.35%) | 3.53% | 35.87% | 21.61% | |
Average Days of Receivables |
18.05 | 26.11 | 18.67 | 17.40 | |
Free Cash Flow per Share |
14.49 | 9.39 | 4.03 | 2.84 | |
Free Cash Flow |
4,379.95 | 2,799.15 | 1,058.48 | 735.64 | |
Capital Expenditures |
(38.62) | (36.14) | (36.37) | (34.13) | |
| Other line items | |||||
Cash ROIC |
66.74% | 40.55% | 25.29% | 19.05% | |
Accounts Receivable Turnover |
23.38 | 17.42 | 23.90 | 25.02 | |
Accounts Payable Turnover |
1.84 | 1.99 | 2.48 | 2.79 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
254.32 | 231.45 | 171.09 | 150.40 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.07) | 0.47 | 0.01 | 0.02 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.86% | 17.09% | 17.52% | 17.76% | |
Share Based Compensation of Revenue |
0.49% | 0.59% | 0.75% | 0.85% | |
Interest Coverage |
39.73 | 0.62 | (22.52) | (8.51) | |
Operating CF/Net income |
8.02 | (71.91) | (2.47) | (3.15) | |
Depreciation/Fixed assets |
0.02 | 0.03 | 0.01 | 0.00 | |
Capex/Depreciation |
(17.29) | (14.85) | (49.89) | (150.35) | |
Revenue per Share |
50.69 | 44.61 | 44.60 | 43.54 | |
Operating CF per Share |
14.62 | 9.51 | 4.17 | 2.97 | |
Capex per Share |
(0.13) | (0.12) | (0.14) | (0.13) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates